Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapyKazuho Miyashita, Yoshiaki Ishigatsubo, Yuki Nakajima et al.|Leukemia Research|2015Cited by 35
Serum ferritin level is a prognostic marker in patients with peripheral T‐cell lymphomaSatoshi Koyama, Hideaki Nakajima, Shin Fujisawa et al.|International Journal of Laboratory Hematology|2016Cited by 35
Comparison of Clinical Features Between Primary and Secondary Breast Diffuse Large B Cell Lymphoma: A Yokohama Cooperative Study Group for Hematology Multicenter Retrospective StudyHiroyuki Takahashi, Hideaki Nakajima, Rika Sakai et al.|Indian Journal of Hematology and Blood Transfusion|2020Cited by 6